With alopecia areata in the headlines, Clinical Trials Arena looks at a potential shake-up in its drug options and an ...

There are many forms or types of alopecia, each presenting with varying amounts of hair loss. Here’s how they appear, how ...

The event will discuss data from emerging OX40/OX40L inhibitors, including Inmagene’s IMG-007 - the only clinical-stage non-depleting anti-OX40 mAb. A live question and answer session will follow the ...

It’s normal to lose about 50 to 100 hairs a day. But it can be upsetting when you notice more hair loss than this, bald ...

Dr. Crystal Aguh’s research shows promising results for reversing “devastating” hair loss. Alopecia, a general term used to ...

Most patients with alopecia areata who had hair regrowth with baricitinib and discontinued maintenance therapy experienced a relapse of hair loss.

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced that Shaperon ...

Bald Atlanta cosmotologist with alopecia will host the third annual Baldie Con at the J.W. Marriott Atlanta Buckhead this weekend ...

As Per , Alopecia Treatment Market Growth is Driven by Rising Demand for Hair Restoration Products, and Technological ...

As our next step for the Adrenaverse platform, we will focus on developing AQST-108 for the treatment Alopecia areata, based on our candidate’s differentiated therapeutic profile and significant unmet ...

The increased interest in alopecia areata comes at a time when the space is undergoing exciting changes, from ongoing clinical trials to the potential of new treatment paradigms, says Dr Emma ...